Results
eNauka >
Results >
HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib
| Title: | HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib | Authors: | Tomasevic, Zoran M; Smyth, LM; Saura, C; Boni, V; Garcia-Saenz, JA; Prat, A; Eli, L; Garza, SJ; Lalani, AS; Crown, JP | Issue Date: | 2019 | Publication: | ANNALS OF ONCOLOGY | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Type: | Conference Paper | Collation: | vol. 30 | WoS-ID: | 000478092400081 | URI: | https://enauka.gov.rs/handle/123456789/813970 | Project: | Puma Biotechnology Inc. | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | Mp. category will be shown later |
3
WEB OF SCIENCETM
Google ScholarTM
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.